Comparisons between the National Comprehensive Cancer Network (NCCN) non‐small‐cell lung cancer (NSCLC) Clinical Practice Guidelines (Chinese version), the NCCN original edition, and the European Society for Medical Oncology NSCLC Guidelines in 2009
Yan Xu,
Hongyu Liu,
Jun Chen,
Qinghua Zhou
|
9 |
2010 |
9
2010
|
Attributable causes of lung cancer incidence and mortality in China
10 auth.
Jian-bing Wang,
Yaguang Fan,
Yong Jiang,
Ping Li,
Hui-juan Xiao,
Wanqing Chen,
...
Wenqiang Wei,
Qing-hua Zhou,
Y. Qiao,
P. Boffetta
|
8 |
2011 |
8
2011
|
Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC)
A. Tan
|
8 |
2020 |
8
2020
|
Epidemiology of lung cancer in China
Wanqing Chen,
R. Zheng,
H. Zeng,
Siwei Zhang
|
8 |
2015 |
8
2015
|
Review of aerobic glycolysis and its key enzymes – new targets for lung cancer therapy
Xue-bing Li,
J. Gu,
Qing-hua Zhou
|
8 |
2015 |
8
2015
|
Epidemiology of lung cancer in China
M. Cao,
Wanqing Chen
|
8 |
2018 |
8
2018
|
Lung cancer incidence and mortality in China, 2011
7 auth.
R. Zheng,
H. Zeng,
T. Zuo,
Siwei Zhang,
Y. Qiao,
Qinghua Zhou,
...
Wanqing Chen
|
7 |
2015 |
7
2015
|
Esophageal cancer statistics in China, 2011: Estimates based on 177 cancer registries
7 auth.
H. Zeng,
R. Zheng,
Siwei Zhang,
T. Zuo,
C. Xia,
X. Zou,
...
Wanqing Chen
|
7 |
2015 |
7
2015
|
ALK‐rearrangement in non‐small‐cell lung cancer (NSCLC)
Xue Du,
Y. Shao,
H. Qin,
Yan-hong Tai,
Hongjun Gao
|
7 |
2018 |
7
2018
|
Curcumin induces ferroptosis in non‐small‐cell lung cancer via activating autophagy
9 auth.
Xin Tang,
H. Ding,
Maoli Liang,
Xing Chen,
Yuxia Yan,
Nan-sheng Wan,
...
Qianqian Chen,
Jing Zhang,
Jie Cao
|
7 |
2021 |
7
2021
|
Traditional Chinese medicine and cancer: History, present situation, and development
Jie Liu,
Shuo Wang,
Ying Zhang,
H. Fan,
Hong-Sheng Lin
|
7 |
2015 |
7
2015
|
Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040
7 auth.
Chunquan Liu,
Yunlei Ma,
Qi Qin,
Pei‐Hao Wang,
Yi Luo,
Peng‐Fei Xu,
...
Yong Cui
|
7 |
2022 |
7
2022
|
Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics
13 auth.
Jie Zhang,
Jing Gao,
Yanyan Li,
Jun Nie,
Ling Dai,
Weiheng Hu,
Xiaoling Chen,
Jindi Han,
Xiangjuan Ma,
Guangming Tian,
...
Di Wu,
L. Shen,
J. Fang
|
6 |
2015 |
6
2015
|
Quercetin induces pro‐apoptotic autophagy via SIRT1/AMPK signaling pathway in human lung cancer cell lines A549 and H1299 in vitro
7 auth.
Heng-juan Guo,
H. Ding,
Xin Tang,
Maoli Liang,
Shuo Li,
Jing Zhang,
...
Jie Cao
|
6 |
2021 |
6
2021
|
Efficacy and safety of nivolumab in non‐small cell lung cancer with preexisting interstitial lung disease
10 auth.
O. Kanai,
Y. H. Kim,
Y. Demura,
M. Kanai,
Tsuyoshi Ito,
K. Fujita,
...
H. Yoshida,
M. Akai,
T. Mio,
T. Hirai
|
6 |
2018 |
6
2018
|
